Balance Sheet
Cash Flow Statement
AmortizationAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Free Cash Flow (2019 - 2025)

Historic Free Cash Flow for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to $33.8 million.

  • Legend Biotech's Free Cash Flow rose 14583.43% to $33.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$213.7 million, marking a year-over-year decrease of 1760.91%. This contributed to the annual value of -$192.2 million for FY2024, which is 5818.62% up from last year.
  • Per Legend Biotech's latest filing, its Free Cash Flow stood at $33.8 million for Q3 2025, which was up 14583.43% from -$3.8 million recorded in Q2 2025.
  • In the past 5 years, Legend Biotech's Free Cash Flow ranged from a high of $33.8 million in Q3 2025 and a low of -$156.3 million during Q4 2021
  • For the 5-year period, Legend Biotech's Free Cash Flow averaged around -$57.3 million, with its median value being -$55.5 million (2023).
  • Its Free Cash Flow has fluctuated over the past 5 years, first tumbled by 851393.6% in 2023, then skyrocketed by 14583.43% in 2025.
  • Quarter analysis of 5 years shows Legend Biotech's Free Cash Flow stood at -$156.3 million in 2021, then soared by 81.56% to -$28.8 million in 2022, then tumbled by 356.25% to -$131.5 million in 2023, then decreased by 7.96% to -$141.9 million in 2024, then soared by 123.82% to $33.8 million in 2025.
  • Its Free Cash Flow was $33.8 million in Q3 2025, compared to -$3.8 million in Q2 2025 and -$101.8 million in Q1 2025.